The antidepressant, which costs $4 for a COVID-19 treatment, has shown early promise. It could be used in combination with other treatments.
- Category
- Health
Be the first to comment
-
Study shows new oral COVID-19 treatment from Merck reduces risk of hospitalization and death
-
Busting long COVID: Treatment in Florida shows early signs of success
-
Experimental treatment shows promise to treat breast cancer
-
Study shows promising treatment tests for those with long COVID
-
Experimental cancer treatment shows promise in joint trial from Moderna and Merck
-
New treatment for rectal cancer shows promise or remission in small clinical trial
-
Monoclonal antibody therapy treatment for moderate to severe atopic dermatitis shows promise
-
Fluvoxamine: a $4 Antidepressant That Reduces COVID 19 Hospitalizations
-
1st ever pill to treat COVID-19 shows promise, Merck says I ABC7
-
Duke researchers' pancreatic cancer treatment shows early promise
-
Jowar Khichdi Recipe | Healthy & Yummy | Gluten Free Weight Loss Millet Recipes | Culinary Aromas
-
৭ দিনে যৌন ক্ষমতা বাড়ানোর কুরআনী চিকিৎসা/ Treatment of metal corrosion disease in Bangla
-
Healthy Lifestyle
Add to playlist
Sorry, only registred users can create playlists.